| Date | Company Name | Details |
|---|---|---|
| 25-May-2026 | Rama Vision | Rama Vision Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 inter alia to consider and approve the Standalone Audited Financial Results for the quarter and financial year ended March 31 2026. |
| 25-May-2026 | Eldeco Housing | Final Dividend & Audited Results Eldeco Housing & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026 both on standalone and consolidated basis and consider & recommend final dividend on the equity shares of the Company, if any, for the financial year ended March 31, 2026. |
| 25-May-2026 | Chennai Meena | Chennai Meenakshi Multispeciality Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) and Regulation 33 of SEBI (Listing Obligation and disclosure Requirements) Regulations, 2015 (LODR), as amended, NOTICE is hereby given that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 25th May, 2026 at 12.00 Noon at the Registered Office of the Company at New No. 70, Old No.149, Luz Church Road, Mylapore, Chennai - 600 004 inter-alia to consider, approve and take on record the Audited Financial Results of the Company for the quarter and year ended March 31, 2026. |
| 25-May-2026 | BCL Industries | BCL Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve Audited Financial Results and Dividend |
| 25-May-2026 | Orchid Pharma | Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter-IV and Financial Year ended on March 31 2026 |
